ClinVar Miner

Submissions for variant NM_001079866.2(BCS1L):c.547C>T (p.Arg183Cys)

gnomAD frequency: 0.00008  dbSNP: rs144885874
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 6
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000006550 SCV000245582 likely pathogenic Mitochondrial complex III deficiency nuclear type 1 2014-12-15 criteria provided, single submitter clinical testing The p.Arg183Cys variant in BCS1L has been identified in 1 compound heterozygous individual with Mitochondrial complex III deficiency (Fernandez-Vizarra 2007). The p.Arg183Cys variant has been identified in 0.023% (1/4406) of African American chromosomes by the NHLBI Exome Sequencing Project (; dbSNP rs144885874). Although this variant has been seen in the general population, its frequency is low enough to be consistent with a recessive carrier frequency. In vitro functional studies suggest that this variant impacts protein function (Fernandez-Vizarra 2007). In summary, although additional studies are required to fully establish its clinical significance, the p.Arg183Cys variant is likely pathogenic.
GeneDx RCV000521027 SCV000617286 pathogenic not provided 2018-10-30 criteria provided, single submitter clinical testing The R183C pathogenic variant in the BCS1L gene has been reported previously in combination with another BCS1L variant in an individual with early-onset encephalopathy and complex III deficiency (Fernandez-Vizarra et al., 2007). The R183C variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The R183C variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species. Functional analysis found that the introduction of R183C into yeast with deletion of the BSC1L gene failed to rescue the cell line (Fernandez-Vizarra et al., 2007). We interpret R183C as a pathogenic variant.
Counsyl RCV000674245 SCV000799548 uncertain significance GRACILE syndrome 2018-04-24 criteria provided, single submitter clinical testing
Invitae RCV000521027 SCV002265125 likely pathogenic not provided 2024-01-04 criteria provided, single submitter clinical testing This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 183 of the BCS1L protein (p.Arg183Cys). This variant is present in population databases (rs144885874, gnomAD 0.008%). This missense change has been observed in individual(s) with Björnstad syndrome (PMID: 17403714). ClinVar contains an entry for this variant (Variation ID: 6174). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt BCS1L protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects BCS1L function (PMID: 17403714). This variant disrupts the p.Arg183 amino acid residue in BCS1L. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 17314340). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.
Baylor Genetics RCV003472991 SCV004210785 likely pathogenic Pili torti-deafness syndrome 2023-10-01 criteria provided, single submitter clinical testing
OMIM RCV000006550 SCV000026733 pathogenic Mitochondrial complex III deficiency nuclear type 1 2007-05-15 no assertion criteria provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.